Douglas Dieterich, MD
- PROFESSOR | Medicine, Liver Diseases
Dr. Dieterich is currently Professor of Medicine in the Division of Liver Diseases and also Director of Continuing Medical Education in the Department of Medicine at Mount Sinai School of Medicine, New York, NY.
He has a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases.
Douglas T. Dieterich graduated from Yale University in New Haven, CT and received his Doctorate of Medicine from New York University of Medicine in NY. He completed his internship and residency in Internal Medicine at the Bellevue Hospital Center in New York, NY where he was also a fellow in the Division of Gastroenterology. He became Clinical Assistant Professor of medicine and then a Clinical Professor of Medicine, both at the New York University. He remains as an Adjunct Clinical Professor of Medicine at New York University School of Medicine.
Dr. Dieterich is an investigator for many ongoing clinical trials evaluating the safety and efficacy of new antiviral treatments for chronic hepatitis B & C.
Dr. Dieterich is a member of many professional societies and is a fellow of both the American College of Physicians and the American College of Gastroenterology. He has served on several committees of the AIDS Clinical Trials Group at the National Institutes of Health (NIH), including the Steering Committee of the Opportunistic Infections Core Committee and the Cytomegalovirus (CMV) Committee. He was Chair and Co-Chair, respectively, of the Enteric Parasites Committee and the Protozoan Committee. He also served on the NIH Study Sections for CMV and cryptosporidiosis.
Widely published, Dr. Dieterich is the author of numerous journal articles, abstracts and book chapters on viral hepatitis and AIDS associated infections of the gastrointestinal tract and liver.
In the News:
Dr. Dieterich discusses how Personal health battles made these doctors betters at their jobs in the New York Post
"Hepatitis C cure eludes patients as states struggle with costs" on NBC News
Dr. Dieterich discusses Why The Benefits of Hepatitis C Drug Therapies Outweigh The Risks
Dr. Dieterich discusses viral hepatitis in The Daily News feature The Daily Check Up.
View the PDF
Dr. Dieterich discusses the advancements in the treatment of Hepatitis C in The Daily News Feature, The Daily Check Up.
See Dr. Dieterich on Facebook Live speaking about "The Silent Virus: Expert Q&A on The Hep C Epidemic"
Please listen to an audio podcast "The Mystery Virus" as part of the "Road to Resilience" series on iTunes and here.
American Board of Internal Medicine
- Colon Polypectomy
- Colon Polyps
- Esophageal Varices
- Flexible Sigmoidoscopy
- Gilbert's Syndrome
- Hepatitis A
- Hepatitis A Vaccine
- Hepatitis B
- Hepatitis B Vaccine
- Hepatitis C
- Portal Hypertension
- Toxic Hepatitis
- Upper GI Endoscopy
- Upper GI Endoscopy, Diagnostic
- Wilson's Disease
MD, New York University School of Medicine
Internship, Internal Medicine, NYU Medical Center
Residency, Internal Medicine, NYU Medical Center
Fellowship, Gastroenterology, NYU Medical Center
Medscape Physician Survey - Mount Sinai ranked in Top 5 for Hepatitis C
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Dieterich during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- GLYCOTEST; Gilead Sciences, Inc.; Intercept Pharmaceuticals Inc.; Swedish Orphan Biovitrum (SOBI)
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- AbbVie Inc.; Gilead Sciences, Inc.; Intercept Pharmaceuticals Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.